Acadian Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,452
| Closed | -$230K | – | 2173 |
|
|
2024
Q3 | $230K | Sell |
16,452
-128,449
| -89% | -$1.8M | ﹤0.01% | 1315 |
|
|
2024
Q2 | $1.19M | Buy |
144,901
+97,020
| +203% | +$797K | ﹤0.01% | 939 |
|
|
2024
Q1 | $368K | Buy |
+47,881
| New | +$368K | ﹤0.01% | 1075 |
|
|
2020
Q3 | – | Sell |
-9,674
| Closed | -$198K | – | 2357 |
|
|
2020
Q2 | $198K | Sell |
9,674
-12,954
| -57% | -$265K | ﹤0.01% | 1491 |
|
|
2020
Q1 | $331K | Sell |
22,628
-11,945
| -35% | -$175K | ﹤0.01% | 1067 |
|
|
2019
Q4 | $491K | Buy |
+34,573
| New | +$491K | ﹤0.01% | 1075 |
|
|
2018
Q3 | – | Sell |
-29,418
| Closed | -$801K | – | 1795 |
|
|
2018
Q2 | $801K | Buy |
+29,418
| New | +$801K | ﹤0.01% | 790 |
|
|
2015
Q4 | – | Sell |
-496
| Closed | -$10K | – | 1508 |
|
|
2015
Q3 | $10K | Sell |
496
-88,993
| -99% | -$1.79M | ﹤0.01% | 1134 |
|
|
2015
Q2 | $2.97M | Buy |
+89,489
| New | +$2.97M | 0.01% | 508 |
|